Biohaven (BHVN) Competitors $13.60 -0.09 (-0.69%) As of 03:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BHVN vs. TLX, AXSM, LNTH, PCVX, CYTK, MRUS, KRYS, MTSR, RNA, and AKROShould you be buying Biohaven stock or one of its competitors? The main competitors of Biohaven include Telix Pharmaceuticals (TLX), Axsome Therapeutics (AXSM), Lantheus (LNTH), Vaxcyte (PCVX), Cytokinetics (CYTK), Merus (MRUS), Krystal Biotech (KRYS), Metsera (MTSR), Avidity Biosciences (RNA), and Akero Therapeutics (AKRO). These companies are all part of the "pharmaceutical products" industry. Biohaven vs. Its Competitors Telix Pharmaceuticals Axsome Therapeutics Lantheus Vaxcyte Cytokinetics Merus Krystal Biotech Metsera Avidity Biosciences Akero Therapeutics Biohaven (NYSE:BHVN) and Telix Pharmaceuticals (NASDAQ:TLX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment. Is BHVN or TLX more profitable? Telix Pharmaceuticals' return on equity of 0.00% beat Biohaven's return on equity.Company Net Margins Return on Equity Return on Assets BiohavenN/A -257.07% -164.01% Telix Pharmaceuticals N/A N/A N/A Does the media favor BHVN or TLX? In the previous week, Biohaven had 6 more articles in the media than Telix Pharmaceuticals. MarketBeat recorded 23 mentions for Biohaven and 17 mentions for Telix Pharmaceuticals. Biohaven's average media sentiment score of 0.11 beat Telix Pharmaceuticals' score of 0.11 indicating that Biohaven is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biohaven 3 Very Positive mention(s) 1 Positive mention(s) 16 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Telix Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 3 Very Negative mention(s) Neutral Which has stronger valuation & earnings, BHVN or TLX? Telix Pharmaceuticals has higher revenue and earnings than Biohaven. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiohavenN/AN/A-$846.42M-$9.36-1.42Telix Pharmaceuticals$516.72M9.24$32.93MN/AN/A Do analysts rate BHVN or TLX? Biohaven currently has a consensus price target of $58.46, indicating a potential upside of 338.74%. Telix Pharmaceuticals has a consensus price target of $22.33, indicating a potential upside of 58.22%. Given Biohaven's stronger consensus rating and higher possible upside, analysts clearly believe Biohaven is more favorable than Telix Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biohaven 0 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 3.07Telix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in BHVN or TLX? 88.8% of Biohaven shares are owned by institutional investors. 16.0% of Biohaven shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryBiohaven beats Telix Pharmaceuticals on 8 of the 12 factors compared between the two stocks. Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHVN vs. The Competition Export to ExcelMetricBiohavenMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.36B$3.04B$5.71B$21.10BDividend YieldN/A2.40%4.60%3.58%P/E Ratio-1.4221.1328.0727.85Price / SalesN/A338.95459.4759.34Price / CashN/A43.2336.5523.00Price / Book3.188.278.614.68Net Income-$846.42M-$55.19M$3.24B$994.49M7 Day Performance-5.09%5.50%3.83%1.53%1 Month Performance-7.08%17.25%10.40%5.79%1 Year Performance-66.86%4.61%34.13%11.35% Biohaven Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHVNBiohaven2.3038 of 5 stars$13.59-0.7%$58.46+330.2%-64.5%$1.39BN/A-1.45239News CoverageTLXTelix PharmaceuticalsN/A$16.50+1.7%$22.33+35.4%N/A$5.58B$516.72M0.00N/ANews CoverageAnalyst RevisionHigh Trading VolumeAXSMAxsome Therapeutics4.7409 of 5 stars$109.68-1.8%$172.33+57.1%+23.2%$5.40B$385.69M-19.01380Analyst RevisionLNTHLantheus4.6964 of 5 stars$71.56+2.0%$131.20+83.3%-37.6%$4.95B$1.53B20.33700Positive NewsPCVXVaxcyte1.8143 of 5 stars$35.64-1.6%$136.50+283.0%-57.4%$4.60BN/A-8.93160News CoveragePositive NewsCYTKCytokinetics4.2146 of 5 stars$36.96-0.7%$70.92+91.9%-34.3%$4.41B$18.47M-6.99250News CoverageMRUSMerus1.9941 of 5 stars$62.37-1.4%$84.64+35.7%+20.1%$4.32B$36.13M-15.2937Upcoming EarningsKRYSKrystal Biotech4.8848 of 5 stars$148.09+0.4%$213.75+44.3%-27.4%$4.28B$290.52M35.60210News CoverageAnalyst ForecastMTSRMetseraN/A$39.91-6.6%$55.00+37.8%N/A$4.19BN/A0.0081Lockup ExpirationGap UpRNAAvidity Biosciences2.159 of 5 stars$34.02+0.8%$66.35+95.0%-25.6%$4.10B$8.93M-11.34190News CoverageAKROAkero Therapeutics3.7794 of 5 stars$51.38-1.3%$82.50+60.6%+88.3%$4.10BN/A-26.3530Positive News Related Companies and Tools Related Companies Telix Pharmaceuticals Alternatives Axsome Therapeutics Alternatives Lantheus Alternatives Vaxcyte Alternatives Cytokinetics Alternatives Merus Alternatives Krystal Biotech Alternatives Metsera Alternatives Avidity Biosciences Alternatives Akero Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHVN) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BHVN Stock Alerts